Drug
SEP-4199 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 2
- first study started
- 2018
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses SEP-4199 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).TerminatedPhase 3Sumitomo Pharma America, Inc.NCT05227209Written as SEP-4199 CR
- A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.TerminatedPhase 3Sumitomo Pharma America, Inc.NCT05169710Written as SEP-4199 CR 200 mg
- A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 DepressionCompletedPhase 2Sumitomo Pharma America, Inc.NCT03543410Written as SEP-4199 200 mg